Under construction – not a live service
Sign in
Taking people in ItalyNo phase

Ultrasound Bone Density Test Compared With DXA Scan for Osteoporosis

Tests an ultrasound bone density device against standard DXA scans in adults with osteoporosis.

Plain-language title generated from the registry record
Registry title: Bone Evaluation by Ultrasound Radiofrequency Echographic Multi Spectrometry (REMS) vs Dual X-ray Absorptiometry (DXA)

Key facts

Where
Milan, ItalySee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 30 and 80 years old?

Source: NCT06371755, who can take part

Where in Italy

  • I.R.C.C.S. Ospedale Galeazzi-Sant'AmbrogioMilan, ItalyTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Paola Pisani
Trial code
NCT06371755
Record updated
5 September 2025
Original description
Bone Density Evaluation by means of the Ultrasound Technology Named Radiofrequency Echographic Multi Spectrometry (REMS) in Comparison With DXA Technique.Read full original descriptionShow less

REMS Versus DXA for Bone Mineral Density (BMD) Evaluation

Bone Density Evaluation by means of the Ultrasound Technology Named Radiofrequency Echographic Multi Spectrometry (REMS) in Comparison With DXA Technique.

Clinical Center involved in the study:IRCCS Orthopedic institute Galeazzi - Sant'Ambrogio The clinical study will evaluate the intra- and inter-operator repeatability of the REMS,(Radiofrequency Echographic Multi Spectrometry) ultrasound diagnostic technology implemented in the EchoStation device (Echolight Spa, Lecce) and the diagnostic accuracy in comparison with DXA (used as standard reference).

Inclusion: patients scheduled for lumbar and/or femoral DXA examination,; female sex,; age range 30-80 years (for repeatability study), age range 50-70 years (for accuracy study),; absence of severe obesity (BMI < 40 kg/m2),; absence of severe walking difficulties,; cognitive underwriting of informed consent.

Exclusion: age below 30 years or over 80 years,; Male sex,; severe walking difficulties,; severe obesity (BMI > 40 kg/m2),; declared pregnancy.

ClinicalTrials.gov NCT06371755